Implications of Multimerin-1 (MMRN-1) expression in adult de novo acute myeloid leukemia: a preliminary study in Delta Egypt
Open Access
- 27 September 2023
- journal article
- research article
- Published by Taylor & Francis in Egyptian Journal of Basic and Applied Sciences
- Vol. 10 (1) , 671-681
Abstract
No abstract availableFunding Information
- no funder (NO)
This publication has 20 references indexed in Scilit:
- Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid LeukemiaCancers, 2019
- Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemiaHaematologica, 2019
- The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemiaNature Communications, 2018
- Epidemiological patterns of leukaemia in 184 countries: a population-based studyThe Lancet Haematology, 2018
- Platelets and cancer angiogenesis nexusCancer and Metastasis Reviews, 2017
- A 17-gene stemness score for rapid determination of risk in acute leukaemiaNature, 2016
- Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)Annals of Oncology, 2015
- Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupClinical Cancer Research, 2015
- Proteomic Analysis for Finding Serum Pathogenic Factors and Potential Biomarkers in Multiple MyelomaChinese Medical Journal, 2015
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001